Effective elimination of Fn and inhibition of KIR2DL1 expression on CD8+ T cells may prolong the survival of ESCC patients, which is very important in the clinical treatment of ESCC and has broad application prospects. The gene discussed is CD8A; the disease is esophageal squamous cell carcinoma.